These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Factor VIII-specific B cell responses in haemophilia A patients with inhibitors. van Helden PM, Van Haren SD, Fijnvandraat K, van den Berg HM, Voorberg J. Haemophilia; 2010 May; 16(102):35-43. PubMed ID: 20536984 [Abstract] [Full Text] [Related]
32. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors. Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A. Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537 [Abstract] [Full Text] [Related]
38. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Reding MT, Lei S, Lei H, Green D, Gill J, Conti-Fine BM. Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225 [Abstract] [Full Text] [Related]
39. Anti-factor VIII antibodies: a 2005 update. Lavigne-Lissalde G, Schved JF, Granier C, Villard S. Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627 [Abstract] [Full Text] [Related]
40. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity. Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F. Acta Haematol; 2005 Oct; 114(2):84-90. PubMed ID: 16103630 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]